HysterSisters Hysterectomy Support and Information
Advertising Info HysterSisters Hysterectomy Support Tutorial

Go Back   Hysterectomy HysterSisters > Hysterectomy News Articles

HysterSisters Articles for Hysterectomy


SHARING IS CARING

FDA Asserts New Policy to Restrict Women’s Access to Bioidentical Hormones

From the Hysterectomy News Articles List

Agency Warns Pharmacies Not to Compound Commonly Prescribed Hormone Treatments, Use the Term “Bio-identical”

January 9, 2008

MISSOURI CITY, Texas – In a series of warning letters to compounding pharmacies across the country, the Food and Drug Administration (FDA) has asserted a policy that would deny hundreds of thousands of women access to many commonly compounded bioidentical hormones, substituting its judgment for that of doctors. Wyeth Pharmaceuticals, the number one manufacturer of synthetic hormone products, petitioned the FDA to do so in October 2005. More than 70,000 doctors, patients, and pharmacists filed comments with the FDA opposing Wyeth’s petition, the vast majority of whom opposed the petition.

“Under this policy, patients will suffer while Wyeth profits,” said L.D. King, executive director of the International Academy of Compounding Pharmacists (IACP). “Thousands of doctors are making patient-by-patient decisions that compounded hormones are medically appropriate, sometimes because Wyeth’s products are found to be ineffective or produce side effects. This is a decision that should be left to doctors.”

In the letters, the FDA states that it will “halt” compounding of medications containing estriol, an estrogen produced by the human body. Estriol is one of the most widely prescribed hormones and is regularly compounded with other bio-identical hormones pursuant to doctors’ prescriptions for women suffering from symptoms of menopause.

Like many commonly prescribed drugs (e.g, Phenobarbital, quinine, tinidazole), estriol has a monograph from the U.S. Pharmacopeia (USP), but is not a component of an FDAapproved drug. When it passed the FDA Modernization Act in 1997, Congress clearly indicated that drugs with a USP monograph could be compounded.

The FDA also stated in its letters that pharmacies may not use the term “bio-identical” to characterize compounded hormone therapies, even though the chemicals used in such compounds are chemically identical to what is produced by the human body. Furthermore, manufacturers of drugs containing the same bio-identical hormones commonly use the term to characterize their products.

The chemical structure of these drugs is indisputable. Pharmacy compounding is a long-standing, state-regulated and medically vital practice. Millions of Americans have unique health needs that off-the-shelf prescription medicines
cannot meet. For them, customized, compounded medications prescribed or ordered by licensed physicians or veterinarians and mixed safely by trained, licensed compounding pharmacists are the only way to better health.

About IACP
The International Academy of Compounding Pharmacists (IACP) is a non-profit association founded in 1991 to protect and promote the art and skill of the compounding pharmacy profession. We represent more than 2,000 pharmacists, physicians, technicians and patients who are committed to the safe practice of pharmacy compounding. We are committed to ensuring the rights of physicians to prescribe, of pharmacists to prepare and of patients to take customized medications that meet their unique, individual needs.
# #

http://www.iacprx.org/site/DocServer...pdf?docID=3281

For HysterSisters Discussion of this press release: Click Here

01-09-2008 - 06:59 PM


SHARING IS CARING


Do you have a question?

If you have a medical support question related to this article, come JOIN US in our HysterSisters Community Forums. You will receive helpful replies to your questions from our members. See you there!


HysterSisters Free Hysterectomy Booklet

What 350,000 Women Know About Hysterectomy with pages of information, helpful tips and hints to prepare and recover from hysterectomy. Free download for members.




HysterSisters Articles

Diagnosis
Options to Hysterectomy
Treatment Alternatives
Pre-Op Hysterectomy
Post-Op Hysterectomy
Separate Surgeries
Hormone and Menopause
Intimacy after Hysterectomy
Pelvic Floor
Separate Surgeries
Fitness after Hysterectomy
GYN Cancer
Breast Health
Grief and Loss
Endometriosis
Uterine Fibroids
GYN Genetics
Hysterectomy Stories
Ask A Doctor




Find a Surgeon

HysterSisters Doctor Directory
Ellen Wilson, M.D.
5323 Harry Hines Blvd - Dept of OBGYN
Dallas TX 75390
214-648-4747
Shaghayegh DeNoble, M.D.
20 Wilsey Square
Suite C
Ridgewood NJ 07450
2019577220
Stephen Zweibach, M.D.
515 S Kings Ave
Brandon FL 33511
8135712777
Debra Richardson, M.D.
Gynecological Oncology Clinic - SW Med
2201 Inwood Road Suite 106
Dallas TX 75390
214-645-4673
Aileen Caceres, M.D.
Center for Specialized Gynecology/Florida Hospital
410 Celebration Place, Suite 302
Celebration FL 34747
(407) 303-4573
Susan D. Hunter, M.D.
626 Ed Carey Dr
Harlingen TX 78550
956-428-4868
Lauren Streicher, M.D.
Gynecologic Specialists of Northwestern, S.C
680 N. Lake Shore Dr., Suite 117
Chicago IL 60611
(312)654-1166
Siobhan Kehoe, M.D.
Gynecological Oncology Clinic - SW Med
2201 Inwood Road Suite 106
Dallas TX 75390
214-645-4673
Lori Warren, M.D.
3900 Kresge Way
Suite 30
Louisville KY 40207
502-891-8700

Advertisement

Hysterectomy News

August 14,2020

CURRENT NEWS

HysterSisters Takes On Partner To Manage Continued Growth And Longevity
I have news that is wonderful and exciting! This week’s migration wasn’t a typical migration - from one set ... News Archive

TODAY'S EVENTS

Calendar - Hysterectomies - Birthdays


Request Information


I am a HysterSister

HYSTERECTOMY STORIES

Featured Story - All Stories - Share Yours

FOLLOW US


Your Hysterectomy Date


CUSTOMIZE Your Browsing  



Advertisement


Advertisement